We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Whitepapers

Novel Technology Expands the Power of DIA-MS content piece image
Whitepaper

Novel Technology Expands the Power of DIA-MS

Download this whitepaper to review the exciting technology behind the advances in data independent acquisition and explore how it can enhance your research.
Principle of Mitochondrial Toxicity Assessment content piece image
Whitepaper

Metabolic Phenotyping to Assess Mitochondrial Toxicity

This whitepaper highlights the key principles of mitochondrial toxicity assessment during drug discovery. It features customized assay solutions and the latest cell energy phenotyping technology.
Batch-to-Batch Consistency of Premium Grade Bioactive Proteins content piece image
Whitepaper

Batch-to-Batch Consistency of Premium Grade Bioactive Proteins

Many novel cell and gene therapies have the potential to offer personalized therapeutic approaches and hold great promise for curing or treating diseases.
Cell Painting – Phenotypic Drug Discovery Re-Imagined content piece image
Whitepaper

Cell Painting – Phenotypic Drug Discovery Re-Imagined

Cell Painting is a multistep process, in which different compartments of cells are labeled with various fluorescent bioprobes to quantitatively profile multiple phenotypic parameters to better understand the effects of chemical compounds, drugs, genes, or other test articles.
The Battle Against COVID-19 content piece image
Whitepaper

The Battle Against COVID-19

The battle against COVID-19 only begins with a test to identify who is infected and who is not. To accelerate an effective response, we have to move beyond the initial diagnosis to prognosis: Who is most susceptible to developing serious, life-threatening symptoms?
COVID-19 and Organoids: Mini Organs With Massive Potential content piece image
Whitepaper

COVID-19 and Organoids: Mini Organs With Massive Potential

Download your whitepaper to learn more about modeling COVID-19 infection in organoids, how to combat COVID-19 variants as well as the future of organoid technology.
Considerations for Efficient Scale-Up of PSCs in Suspension Culture content piece image
Whitepaper

Considerations for Efficient Scale-Up of PSCs in Suspension Culture

Download this whitepaper to discover scale-up considerations such as suspension culture passaging strategies, medium exchange strategies plus suspension culture seeding density.
Aberrant Cytokine Activity in the Host Immune Response to COVID-19 Leads to Cytokine Release Syndrome content piece image
Whitepaper

Aberrant Cytokine Activity in the Host Immune Response to COVID-19 Leads to Cytokine Release Syndrome

Since the first cases of COVID-19 were identified in December 2019, the disease has spread across the world, claiming over half a million lives and affecting millions of others.
Autologous CAR T-Cell Manufacturing content piece image
Whitepaper

Autologous CAR T-Cell Manufacturing

Cell-based chimeric antigen receptor (CAR) T-cell therapies have rapidly advanced from preclinical research. This success has driven an influx of companies to further develop CAR T-cell constructs to make them more effective, safe and persistent.
Challenging Host Cell Protein Assays for Improved Risk Mitigation content piece image
Whitepaper

Challenging Host Cell Protein Assays for Improved Risk Mitigation

At high levels, host cell proteins (HCPs) can cause immunogenic responses and reduced efficacy of biologics, so it is imperative to have an effective, robust HCP assay to detect them and mitigate these effects.
Advertisement